Fedor Heidenreich
Antea Group (France)(FR)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Monoclonal and Polyclonal Antibodies Research, Myasthenia Gravis and Thymoma, Autoimmune Neurological Disorders and Treatments
Most-Cited Works
- → Benefit of interferon β-1a on MSFC progression in secondary progressive MS(2002)403 cited
- → A point mutation in PTPRC is associated with the development of multiple sclerosis(2000)195 cited
- → Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite(2003)190 cited
- → Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)(2021)181 cited
- → An accurate fully automated panel of plasma biomarkers for Alzheimer's disease(2022)162 cited
- → Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression(2002)158 cited
- → Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging(1995)151 cited
- → The spectrum of mutations causing end-plate acetylcholinesterase deficiency(2000)120 cited
- → The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls(2001)116 cited
- → Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage(2013)113 cited